Neuro 2 Flashcards
Barbituates:
Name (4)
- phenobarbital
- pentobarbital
- thiopental (only one commonly used now)
- secobarbital
Barbituates:
MOA
Clinical Use (2)
“BarbiDURATes INCREASE DURATION”
-Facilitate GABA-A action by INCREASE DURATION of Cl- channel opening–>decrease neuron firing
- Sedative for anxiety/seizures/insomnia
- induction of anesthesia (THIOPENTAL)
“Barbie likes it to last longer, while Ben likes it more frequently” (yes, barbie dumped ken for ben)
Barbituates:
Adverse(4)
Contra(1)
Overdose treatment
- Respiratory & Cardiovascular depression (can be fatal)
- CNS depression (exacerbated by ETOH)
- Dependence
- P450 inducer
- Contra: Porphyrias
- Overdose tx: supportive (assist resp. and maintain BP)
Benzodiazepines:
Name 8
- Diazepam
- Lorazepam
- Triazolam
- Temazepam
- Oxazepam
- Midazolam
- Chlordiazepoxide
- Alprazolam
Benzodiazepines:
MOA
Which have short half-lives? Why does this matter?
“FREnzodiazepines INCREASE FREQUENCY”
-Facilitate GABA-A action by INCREASE FREQUENCY of Cl- channel opening
- Most drugs have long half-lives and active metabolites except ‘ATOM’
1. Alprazolam
2. Triazolam
3. Oxazepam
4. Midazolam - these are short acting–>higher addiction potential
What 3 drugs all bind the GABA-A Receptor?
What type of receptor is it?
- Benzo
- Barbs
- Alcohol
- Ligand-gated Cl- channel
Benzodiazepines: Clinical uses (8)
- Anxiety
- spasticity
- Status epilepticus (lorazepam/diazepam/midazolam)
- eclampsia
- detox (esp ETOH-withdrawal)
- Night terrors/ sleep walking (increase STAGE2/ decrease STAGE4&REM)
- General anesthetic (amnesia, muscle relaxation)
- hypnotic (insomnia)
What 3 benzo’s are used to treat status epileptics
- Diazepam
- lorazepam
- midazolam
Benzodiazepines:
Adverse
Comparison to Barbituates
Overdose treatment
- dependence
- CNS depression (exacerbated by ETOH)
- precipitate seizures w/ causing Acute Benzo if chronic Benzo use
- Benzos safer than Barbs b/c less respiratory depression, coma, antidote available
- Overdose tx: Flumazenil (competitive GABA:Benzo-R antagonist
Non-benzodiazepine Hypnotics:
Name 3
“all ZZZs put you to sleep”
- Zolipidem
- Zaleplon
- esZopiclone
Non-benzodiazepine Hypnotics: MOA Effect on sleep cycle Clinical Use (1) Duration?
- Bind BZI subtype of GABA-R
- Sleep cycle less affected (no change in REM) as compared with Benzos
- insomnia
- short duration b/c rapidly metabolized by liver
Non-benzodiazepine Hypnotics:
Adverse (2)
Antidote
- Ataxia
- HA/ confusion
-effects reversed by Flumazenil
Non-benzodiazepine Hypnotics:
Compare to older sedative hypnotics(4)
- Modest day-after psychomotor depression
- few amnestic effects
- less dependence risk than Benzos
- lower abuse potential (increase dose= increase GI upset)
2 ways for local anesthetic to cross BBB?
- lipid soluble
2. active transport
Drugs with decreased solubility in blood have what kind of onset/duration?
Example?
rapid induction & rapid recovery times
- Nitrous Oxide (N2O) has low blood/low lipid solubility
- -> fast induction & low potency
Describe MAC
Minimal Alveolar Concentration
=concentration required to prevent 50% of subjects from moving in response to noxious stimulus
what’s the relationship btw potency and MAC
inverse
potency= 1/MAC
What effect does increased drug solubility in lipids have on potency?
Example?
increase lipid solubility = increase potency
- Halothane has high lipid/blood solubility–> slow induction and high potency
Inhaled anesthetics:
7
all end in “-ane” except N2O
- Desflurane
- Halothane
- Enflurane
- Isoflurane
- Sevoflrane
- Methoxyflurane
- N2O
What kind of effect does N2O as a inhaled anesthetic?
Not strong enough to suppress CNS alone but potentiates other drugs when used in combo
Inhaled anesthetics:
MOA
Effects (4)
- Unknown MOA
- Myocardial depression
- respiratory depression
- increased cerebral blood flow (decrease cerebral metabolic demand)
- N/V (couple with anti-emetic post-surgery)
Inhaled anesthetics: Adverse 1. Halothane 2. Methoxyflurane 3. Enflurane 4. N2O
- ‘H’alothane–> ‘H’epatotox
- Methoxyflurane –>Nephrotox
- ‘E’nfluane–> ‘E’pileptic potential
- N2O–>expansion of trapped gases in body cavity
Describe Malignant Hyperthermia
Etiology
-rare, life-threatening condition in which inhaled anesthetics or succinylcholine induce F/Severe Muscle contractions
- Autosomal Dominant with variable penetrance
- Mutation in VSens RyR–>increase Ca+2 release from SR
Treatment for Malignant Hyperthermia
MOA
Dantrolene, RyR antagonist
IV anesthetics:
Name 5
“The Mighty King Proposes Foolishly to Oprah”
- Thiopental (Barb)
- Midazolam (Benzo)
- Ketamine (Arylcyclohexylamines)
- Propofol
- Opioid (morphine/ fentanyl)
Thiopental: Potency Lipid Solubility Brain entry/ brain effect Use
- high potency
- high lipid solubility
- rapid entry into brain/ decrease cerebral blood flow
Use: induction of anesthesia and Short surgical procedures
Thiopental:
elimination
rapid redistribution into tissue and fat
Midazolam: Use Admin w/... Adverse (3) Treatment of overdose
- endoscopy (short procedure where you don’t need to put patient completely under
Admin with Gaseous Anesthetics and Narcotics
Adverse:
- severe post-op Respiratory depression
- decrease BP
- anterograde amnesia
Overdose tx: Flumazenil
Ketamine ( a Arylcyclohexylamines)
MOA
Heart effects, CNS effects
Adverse (2)
PCP analog–>block NMDA-R
- cardiovascular stimulants/ increase cerebral blood flow
- disorientation
- hallucination/ bad dreams
Propofol: MOA induction Use(2) comparison to thiopental
- potentiates GABA-A and inhib NMDA-R (‘pro’ GABA-a, ‘fool’ NMDA-R)
- rapid induction
- Sedation in ICU
- short procedures
Less post-op Nausea than thiopental
Opioids:
Name 2 IV
MOA
- Morphine
- Fentanyl
-bind mu-R and typically combined with other CNS depressants during general anesthesia
which IV anesthetic increases cerebral b.flow?
decreases?
increase = ketamine decrease= thiopental
Effect of COPD/atelectasis on induction time for inhaled anesthetics
increase Dead space–>increase time of anesthetic to become effective
Effect of increased HR on induction time
increase HR–> increase b.flow–>
decrease partial pressure of drug (dilutes drug in blood)
–> increase time of anesthetic to become effective
MAC not affected by:
- Type of Noxious stimulus
- Sex
- Height
- Weight
- Duration of exposure
How is MAC affected by: Age Hyperthyroidism Sedative interaction Amphetamine interaction Red hair
- MAC is approximated for a 40yo, increase MAC in infancy and decrease MAC in old age
- hyperthyroidism- increase MAC
- Sedative- decrease MAC
- Amphetamine- increase MAC
- Red hair- increase MAC
Local Anesthetics: Name Esters (4)
- Procaine
- Cocaine
- Tetracaine
- Benzocaine
Local Anesthetics:
Amides (3)
“am’I’des have 2 I’s in name”
- Lidocaine
- Mepivacaine
- Bupivacaine
Local Anesthetics:
MOA
block Na+ channels by binding inner portion of receptor
Local Anesthetics:
Order of Neuron affected
Order of sensation loss
- most effective in rapidly firing neurons
- small myelinated >small unmyelinated> large myelinated > large unmyelinated
-pain > temp > touch > pressure
Local Anesthetics:
Structure/charge
Affect of Infection in area to drug effect
- tertiary –> penetrate membrane in uncharged form then binds to ion channel as charged form
- In infected/acidic tissue, alkaline anesthetics are charged and can’t penetrate membrane effectively —> NEED MORE ANESTHETIC
Local Anesthetic:
Use
Allergy
- Minor surgical procedures
- spinal anesthesia
- if allergic to esters, give amides
Local Anesthetics:
Adverse
- CNS excitation
- Severe cardiovascular tox (Bupivacaine)
- HTN, Hypotension, Arrhythmia (cocaine)
4 Methemoglobinemia (Benzocaine)
Neuromuscular blocking drugs:
Clinical Uses
Muscle paralysis in surgery or Mechanical Ventilation
selective for motor nicotinic-R
Depolarizing Neuromuscular Blocking Drugs: Name Drug (1)
Succinylcholine
Succinylcholine:
MOA
Strong Ach-R agonist–>produces sustained depolarization and prevents muscle contraction
Succinylcholine:
Phase I vs Phase2 block
Phase I: prolonged depolarization–>Flaccid paralysis
- No Antidote
- Potentiated by AchEi
Phase 2: repolarized but desensitized
- Ach-R are available
- reversed with AchEi
Succinylcholine:
Complications (3)
- hypercalcemia
- hyperkalemia
- malignant hyperthermia
Nondepolarizing Neuromuscular Blocking Drugs: Name Drugs (6)
“containe -cur-“ in them
- Tubocurarine
- atracurium
- mivacurium
- pancuronium
- vecuronium
- rocuronium
Nondepolarizing Neuromuscular Blocking Drugs:
MOA
Reversal(3)
- competitive antagonists- compete with Ach for receptor
- Reversal:
1. Neostigmine (w/atropine to prevent bradycardia)
2. edrophonium
3. other cholinesterase inhibitors
Dantrolene:
MOA
Clinical Use(2)
- binds RyR to prevent Ca+2 release from SR
- Malignant Hyperthermia
- Neuroleptic Malignant Syndrome
Baclofen:
MOA
Clinical Use (3)
-Activates GABA-b-R at spinal cord level–>skeletal muscle relaxation (PERIPHERAL)
- Muscle spasms (acute low back pain)
2 Post-spinal injury - MS
Cyclobenzaprine: MOA Structurally similar to what? Clinical Use (1) Adverse
-CENTRALLY acting sk.muscle relaxant.
Structurally similar to TCAs
- Muscle spasms (not neuro-related)
Adverse similar to anticholinergic drugs.
- Drowsiness
- Dry mouth
- Dizzy
- Blurred Vision
NT changes in Parkinson’s disease
decrease DA
increase Ach
Parkinson’s Disease drugs (5)
“BALSA”
- Bromocriptine
- Amantadine
- Levodopa (w/ carbidopa)
- Selegiline (and COMT inhibitors
- Antimuscarinics (Benztropine)
Which parkinson’s drug inhibits DOPA decarboxylase (DDC)?
Overall effect
Carbidopa
prevents peripheral L-DOPA –> dopamine conversion
Name the 2 COMT inhibitors.
Overall effect
Which crosses the BBB?
- Entacapone (‘can’t get ENTA the brain’)
- Tolcapone (‘can go TOLtally everywhere’)
prevents L-Dopa breakdown into 3-O-methyldopa (3-OMD)
Name the 2 MAO inhibitor used in Parkinson’s.
What specific MAOi do they inhibit
Overall effect
- Selegiline= enhances response to L-DOPA
- Rasagiline
- inhib MAO-Type B
- prevent Dopamine –> DOPAC conversion
Name 3 Dopamine agonists in PD.
Which are ergots and which are non-ergots?
Ergot:
1. Bromocriptine
Non-Ergot
- Pramipexole
- Ropinirole
Drug which increases dopamine availability in PD?
Adverse
Amantadine (increase DA release, decrease DA reuptake)
Adverse:
- Ataxia
- Livedo reticularis (purple lacey skin- may want to google picture)
Agents which increase L-DOPA availability in Pd
Agents prevent PERIPHERAL L-DOPA degradation–> increase L-DOPA entering CNS to be converted to Dopamine centrally
- Levodopa (w/ carbidopa)- blocks DDC, reduces Levodopa side effects of N/V
- Entacapone & Tolcapone- block COMT
Agents which prevent DA breakdown in PD
Agents act CENTRALLY to inhib breakdown of dopamine
- Selegiline- block MAO-B (adverse= orthostatic hypotension)
- Tolcapone- block COMT centrally
Agents which curb excess cholinergic activity in PD
Benzotropine (“PARK your Mercedes-BENZ”)
-improves tremor and rigidity but has little effect on bradykinesia in Parkinsons
Levodopa/ carbidopa:
MOA
Adverse (2)
- L-DOPA can cross BBB –> converted by central -DDC to dopamine
- peripheral DDC is inhibited by Carbadopa
- this combo together increases the bioavailability of L-DOPA in brain with limited adverse
- Arrhythmias (from peripheral formation of catecholamines)
- Dyskinesia-Akinesia (‘on-off’) symptoms (long-term use)
Selegiline, Rasagiline:
MOA
Clinical Use
Adverse (1)
-inhib MAO-B–>increase dopamine availability
Use: adjunct agent to L-dopa in PD
Adverse: enhance effects of L-dopa
Alzheimers drugs:
Name (5)
NMDA-R antagonist
1. Memantine
AchEi
- Donepezil
- galantamine
- rivastigmine
- tacrine
Memantine:
MOA
Use
Adverse (2)
- non-competitive NMDA-R antagonist–> prevent excitotox mediated by Ca+2
- Alzheimer drugs
- Dizzy/confusion
- Hallucinations
Donepezil, galantamine, rivastigmine, tacrine:
MOA
Use
Adverse (3)
- AchEi–> increase Ach
- Alzheimer treatment: don’t change disease course but may slow progression
- N
- Dizzy
- insomnia
Huntington Disease:
Name 3 drugs
- Tetrabenazine
- Reserpine
- Haloperidol
Tetrabenazine, reserpine:
MOA
Use
Adverse (2)
- inhib vesicular monoamine transporter (VMAT) –> decrease dopamine vesicle packaging and release
-Huntington disease
Adverse: monitor for hypotension and depression
Haloperidol:
MOA
Use
- D2-R antagonist
1. Huntington disease
2. Anti-psych drug
Riluzole:
MOA
Effect
- unknown MOA
- decrease glutamate excitotoxicity –> increase survival
“For LOU Gehrig disease, give riLOUzole”
Triptans:
Name (1)
MOA
Sumatriptan (nasal or pill)
- 5-HT1b/1d agonists.
1. inhib CN V
2. prevent vasoactive peptide release
3. induce vasoconstriction
Triptans:
Use (2)
Adverse (2)
Contra (2)
Use: 1. Acute migraine 2. cluster HA
Adverse: 1. Coronary vasospasm 2. mild paresthesia
Contra: 1. CAD(caution in elderly) 2. Pritzmetal angina
Drugs causing Cinchonism (2)
- Quinidine
2. Quinine
Drugs causing Parkinson-like syndromes (3)
“cogwheel rigidity of ARM”
- Antipsychotics
- Reserpine
- Metoclopramide
Drugs causing Seizures(4)
“with seizures, I BItE my tongue”
- Isoniazid (B6 def)
- Buproprion
- Imipenem/cilastatin
- Enflurane
Drugs causing Tardive Dyskinesia (2)
- Antipsychotics
2. Metoclopramide
Drugs causing Nephrotoxicity/ Ototoxicity (4)
- Aminoglycosides
- Vancomycin
- Loop diuretics
- Cisplatin (may respond to amifostine)